Expansion builds on successful collaboration across Latin America and reinforces commitment to advancing innovative cardiometabolic therapies across international markets.
Arcera provides medicines to patients across some of the world’s most dynamic and underserved healthcare markets. Through deep regulatory expertise, established commercial infrastructure, and a...
Abu Dhabi, UAE – June 03, 2026: M42, a global health leader powered by technology, artificial intelligence, and genomics, and...
Acino, part of Arcera in Ukraine has been named one of the Top 50 best employers in Ukraine and ranked...
The partnership establishes a framework to strengthen local manufacturing, develop talent, and support long-term supply resilience. Abu Dhabi, United Arab...
Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences...
Artificial intelligence is no longer a distant promise for healthcare. From accelerating drug discovery to improving clinical decision-making and optimizing...
Every action creates a ripple, and at Arcera, some of the most powerful ripples are created by the women who...
Arcera has successfully implemented a new electronic Quality Management System (eQMS) consisting of six SmartSolve modules across 12 locations and corporate...